Two-Day Special Event Will Showcase The Latest Innovations in Eye Care OAKLAND, N.J.–(BUSINESS WIRE)–#RDx–Topcon Healthcare, a leading provider of medical devices and software solutions for the global eye care community, announced today that it will host a two-day virtual symposia and expo
FILE – In this Tuesday, Nov. 24, 2020 file photo, Vice President-elect Kamala Harris speaks as she and President-elect Joe Biden introduce their nominees and appointees to key national security and foreign policy posts at The Queen theater, in Wilmington, Del. Vice
Dwayne “The Rock” Johnson is returning to the small screen with the help of NBC. — FOX News
FILE – In this March 4, 2020, file photo Chairman of the Joint Chiefs of Staff Gen. Mark Milley testifies to Senate Armed Services Committee about the budget on Capitol Hill in Washington. President-elect Joe Biden will inherit Milley as his senior
This satellite photo combo provided Sunday Jan. 17, 2021 by Planet Labs, Inc. shows the destruction of U.N. World Food Program warehouses at the Shimelba refugee camp in Ethiopia’s Tigray region on Jan. 5, 2021, bottom center left, and before it was
Supporters of leading opposition challenger Bobi Wine cheer as election officials count the ballots after polls closed in Kampala, Uganda, Thursday, Jan. 14, 2021. Ugandans voted in a presidential election tainted by widespread violence that some fear could escalate as security forces
The campaign is unfolding in India, a country that has reported more than 10 million coronavirus infections. — NYT: Top Stories
FILE – In this Dec. 23, 2020 file photo, a woman participates in a protest against Brazilian President Jair Bolsonaro’s handling of the new coronavirus pandemic in Brazilia, Brazil. The country hasn’t approved a single vaccine yet, and independent health experts who
First HER2 directed medicine approved for patients with gastric cancer in a decade TOKYO & MUNICH & BASKING RIDGE, N.J.–(BUSINESS WIRE)–Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved in the U.S. for the treatment of